Skip to main content
. 2013 May 6;14(3):177–191. doi: 10.1120/jacmp.v14i3.4262

Table 3.

Average difference in D99 of the Prostate‐CTV between the daily and planned dose.

CTV Expansion (39)
Registration Methods 0 2 4 6/4
ROT_NC
8.0±12.3%
22.0±16.2%
28.7±15.8%
39.0±15.3%
ROT_C
3.6±9.0%
15.1±15.2%
20.4±14.7%
31.9±15.1%
ContourT
1.6±5.2%
11.3±15.0%
15.6±14.4%
28.3±16.3%
Improvement by correction 4.4% 6.9% 8.3% 7.1%

Note: The differences are expressed in percentage (%) of the planned D99 of the prostate as a function of CTV expansion margins. Negative mean value indicates less dose in daily D99 of the Prostate‐CTV when compared to the planned dose.